Search

everythinglearnresearchcommunity

for

Search:↓

A child has a rare hair and skin disorder due to specific gene variants, suggesting broader genetic testing is needed.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Isotretinoin can cause hair loss, and reducing the dose or using supplements like vitamin D and iron may help.

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Finasteride helps female-pattern hair loss.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

Blocking Prostaglandin D₂ may help treat hair loss.

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

Alopecia areata might help slow down certain cancers.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Double-stranded RNA activates a pathway that causes a skin protein to be expressed in the wrong place.